Cargando…
Tat-Based Therapies as an Adjuvant for an HIV-1 Functional Cure
The human immunodeficiency virus type 1 (HIV) establishes a chronic infection that can be well controlled, but not cured, by combined antiretroviral therapy (cART). Interventions have been explored to accomplish a functional cure, meaning that a patient remains infected but HIV is undetectable in th...
Autores principales: | Jin, Hongping, Li, Dongsheng, Lin, Min-Hsuan, Li, Li, Harrich, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232260/ https://www.ncbi.nlm.nih.gov/pubmed/32276443 http://dx.doi.org/10.3390/v12040415 |
Ejemplares similares
-
Strong In Vivo Inhibition of HIV-1 Replication by Nullbasic, a Tat Mutant
por: Jin, Hongping, et al.
Publicado: (2019) -
Overexpression of PRMT6 does not suppress HIV-1 Tat transactivation in cells naturally lacking PRMT6
por: Sivakumaran, Haran, et al.
Publicado: (2013) -
A HIV-1 Tat mutant protein disrupts HIV-1 Rev function by targeting the DEAD-box RNA helicase DDX1
por: Lin, Min-Hsuan, et al.
Publicado: (2014) -
Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein
por: Jin, Hongping, et al.
Publicado: (2016) -
A mutant Tat protein inhibits infection of human cells by strains from diverse HIV-1 subtypes
por: Rustanti, Lina, et al.
Publicado: (2017)